These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
151 related items for PubMed ID: 34166796
1. Juvenile Paget's Disease: Report of a successful treatment throughout the complete growth of a patient with a missense TNFRSF11B mutation. Prata AR, Saraiva J, Salgado M, Estanqueiro P. Joint Bone Spine; 2021 Dec; 88(6):105243. PubMed ID: 34166796 [Abstract] [Full Text] [Related]
8. Denosumab treatment for juvenile Paget's disease: results from two adult patients with osteoprotegerin deficiency ("Balkan" mutation in the TNFRSF11B gene). Polyzos SA, Singhellakis PN, Naot D, Adamidou F, Malandrinou FC, Anastasilakis AD, Polymerou V, Kita M. J Clin Endocrinol Metab; 2014 Mar; 99(3):703-7. PubMed ID: 24433001 [Abstract] [Full Text] [Related]
9. Polymorphisms of CSF1 and TM7SF4 genes in a case of mild juvenile Paget's disease found using next-generation sequencing. Donáth J, Speer G, Kósa JP, Árvai K, Balla B, Juhász P, Lakatos P, Poór G. Croat Med J; 2015 Apr; 56(2):145-51. PubMed ID: 25891874 [Abstract] [Full Text] [Related]
10. An intermediate form of juvenile Paget's disease caused by a truncating TNFRSF11B mutation. Janssens K, de Vernejoul MC, de Freitas F, Vanhoenacker F, Van Hul W. Bone; 2005 Mar; 36(3):542-8. PubMed ID: 15777670 [Abstract] [Full Text] [Related]
11. [Cytokines in bone diseases. Osteoprotegerin and juvenile Paget's disease]. Hosogane N, Miyamoto T. Clin Calcium; 2010 Oct; 20(10):1540-4. PubMed ID: 20890037 [Abstract] [Full Text] [Related]
13. Acquired resistance to pamidronate treated effectively with zoledronate in juvenile Paget's disease. Gonc EN, Ozon A, Buyukyilmaz G, Alikasifoglu A, Simsek OP, Kandemir N. Osteoporos Int; 2018 Jun; 29(6):1471-1474. PubMed ID: 29502293 [Abstract] [Full Text] [Related]
14. Early identification of a 12-bp tandem duplication in TNFRSF11A encoding receptor activator of nuclear factor-kappa B (RANK): Clinical characterization and response to bisphosphonate therapy. Craven M, Vajravelu ME, Shekdar KV, Levine MA, Mumm S, Whyte MP, Mancilla EE. Bone; 2023 May; 170():116698. PubMed ID: 36740137 [Abstract] [Full Text] [Related]
15. Osteoprotegerin deficiency and juvenile Paget's disease. Whyte MP, Obrecht SE, Finnegan PM, Jones JL, Podgornik MN, McAlister WH, Mumm S. N Engl J Med; 2002 Jul 18; 347(3):175-84. PubMed ID: 12124406 [Abstract] [Full Text] [Related]
16. Auricular ossification: A newly recognized feature of osteoprotegerin-deficiency juvenile Paget disease. Gottesman GS, Madson KL, McAlister WH, Nenninger A, Wenkert D, Mumm S, Whyte MP. Am J Med Genet A; 2016 Apr 18; 170A(4):978-85. PubMed ID: 26762549 [Abstract] [Full Text] [Related]
18. Genotype-phenotype correlation in juvenile Paget disease: role of molecular alterations of the TNFRSF11B gene. Brunetti G, Marzano F, Colucci S, Ventura A, Cavallo L, Grano M, Faienza MF. Endocrine; 2012 Oct 18; 42(2):266-71. PubMed ID: 22638612 [Abstract] [Full Text] [Related]
19. [Paget's disease: case report]. Wegierska M, Ignaczak P, Zalewska J, Jeka S. Ann Acad Med Stetin; 2011 Oct 18; 57(3):64-9; discussion 69. PubMed ID: 23383549 [Abstract] [Full Text] [Related]
20. Loss of Functional Osteoprotegerin: More Than a Skeletal Problem. Grasemann C, Unger N, Hövel M, Arweiler-Harbeck D, Herrmann R, Schündeln MM, Müller O, Schweiger B, Lausch E, Meissner T, Kiewert C, Hauffa BP, Shaw NJ. J Clin Endocrinol Metab; 2017 Jan 01; 102(1):210-219. PubMed ID: 27809640 [Abstract] [Full Text] [Related] Page: [Next] [New Search]